Plano-based Stellus Rx has received a strategic investment from WindRose Health Investors, a New York-based healthcare private equity firm, as the company looks to scale its pharmacist-led approach to medication management.
Financial terms of the transaction were not disclosed.
Stellus Rx operates a technology-enabled pharmacy care management platform focused on value-based outcomes. Through pharmacist-led services, the company works with healthcare providers, payors, and employers to help patients better manage prescribed medications, improve adherence, and reduce overall healthcare costs.
CEO Tony Willoughby said the investment will support the company’s continued expansion.
“This partnership with WindRose marks a significant milestone for Stellus Rx as we continue to scale our pharmacist-led platform,” Willoughby said in a statement.
He said the company’s goal is to help more patients receive the full benefit of their prescribed medications through a more supported care experience.
Backing growth in value-based pharmacy care
WindRose said the investment will support the expansion of Stellus Rx’s clinical and operational capabilities, as well as the scaling of its platform to serve additional patient populations nationwide.
Alex Buzik, a partner at WindRose, said the firm was drawn to Stellus Rx’s focus on outcomes.
“Stellus Rx is a highly differentiated, technology-enabled platform with a proven ability to improve healthcare quality and lower total medical costs,” Buzik said. He added that WindRose plans to work with the management team to expand the model.
Stellus Rx said its services are designed to be particularly effective for patients with chronic and complex conditions. Its care model combines pharmacist-led clinical support with technology-enabled outreach, timely interventions, and dispensing services aimed at improving health outcomes while lowering the total cost of care.
The company said its technology-enabled teams connect directly with patients to optimize medication use and help guide them toward healthier behaviors as part of a more coordinated medication experience.
Robert W. Baird & Co. served as financial advisor to Stellus Rx on the transaction, with Goodwin Procter LLP acting as legal advisor. McDermott Will & Schulte LLP served as legal advisor to WindRose, and TripleTree acted as financial advisor to WindRose.
Don’t miss what’s next. Subscribe to Dallas Innovates.
Track Dallas-Fort Worth’s business and innovation landscape with our curated news in your inbox Tuesday-Thursday.


![Social entrepreneur Byron Sanders, a former nonprofit exec, is CEO of Arete Health, launched in January 2025. [Photo: Michael Samples]](https://s24806.pcdn.co/wp-content/uploads/2025/10/27_ByronSanders-STEM-STEAM-STREAM-970_courtesy_Oct2019-1.jpg)









